More than 500 million people worldwide are persistently infected with the hepatitis B virus
(HBV) and/or hepatitis C virus (HCV) and are at risk of developing chronic liver disease …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) share common mode of transmission
and both are able to induce a chronic infection. Dual HBV/HCV chronic coinfection is a fairly …

In patients with HBV and HCV coinfection, HBV reactivation leading to severe hepatitis has
been reported with the use of direct-acting antivirals (DAAs) to treat HCV infection. Here we …

Hepatitis C virus (HCV) can cause liver disease of variable severity. Expansion of
preexisting memory CD8 T cells by cross-reactivity with a new heterologous virus infection …

Chronic hepatitis B and C cause significant morbidity and mortality worldwide. Antiviral
therapy suppresses but does not eliminate chronic hepatitis B virus (HBV) infection, and it is …

Occult HBV infection is a well‐recognised clinical entity characterised by the detection of
HBV‐DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen …

To characterize acute‐phase hepatitis B virus (HBV)‐specific T cell responses associated
with self‐limited and persistent HBV infections, we compared a patient with acute HBV/HCV …

There is significant upregulation of interleukin-18 (IL-18) expression in viral infectious
diseases and in some chronic hepatic diseases, especially (i) hepatitis C virus (HCV) …

Coinfection with other hepatitis viruses modifies the viral profile in serum and leads to more
liver damage and more rapid progression during the course of hepatitis C virus infection …

Hepatitis B virus (HBV) infection is the leading cause of liver cirrhosis and hepatocellular
carcinoma worldwide. In recent decades, significant progress toward understanding the …